Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
Journal of Virology|October 1, 2020
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite NeutralizersAnna Schorcht, Tom L G M van den Kerkhof, Christopher A Cottrell, et al.
Cell Reports. Medicine|March 2, 2022
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionGuidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
Journal of Virology|October 20, 2021
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous NeutralizationAnna Schorcht, Christopher A Cottrell, Pavel Pugach, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature|September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceJinghe Huang, Byong H Kang, Marie Pancera, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Science Immunology|May 26, 2021
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccineesDaryl Geers, Marc C Shamier, Susanne Bogers, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
Journal of Virology|October 1, 2020
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite NeutralizersAnna Schorcht, Tom L G M van den Kerkhof, Christopher A Cottrell, et al.
Cell Reports. Medicine|March 2, 2022
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionGuidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
Journal of Virology|October 20, 2021
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous NeutralizationAnna Schorcht, Christopher A Cottrell, Pavel Pugach, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Plos Pathogens|October 3, 2024
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopesMitch Brinkkemper, Gius Kerster, Philip J M Brouwer, et al.
Nature|September 5, 2014
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interfaceJinghe Huang, Byong H Kang, Marie Pancera, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Science Immunology|May 26, 2021
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccineesDaryl Geers, Marc C Shamier, Susanne Bogers, et al.
Pageof 33